O'KEEFE D'ELIA: Open Payments
NPI 1316517543 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,554 in 77 payments from 7 companies in 2025. Trend: 2023 $715 · 2024 $1,005 · 2025 $1,554
Food & beverage: $1,443Education: $111
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 35 | $664 |
| Janssen Pharmaceuticals, Inc | 13 | $311 |
| E.R. Squibb & Sons, L.L.C. | 14 | $233 |
| Teva Pharmaceuticals USA, Inc. | 7 | $181 |
| Otsuka America Pharmaceutical, Inc. | 5 | $110 |
| Vanda Pharmaceuticals Inc. | 2 | $29 |
| Alkermes, Inc. | 1 | $26 |
Products named: INGREZZA, INVEGA SUSTENNA, COBENFY, ABILIFY ASIMTUFII, UZEDY, FANAPT, ARISTADA.
Industry payments across FL — which companies pay providers there.
